Anti-Inflammatory Activities of Grapes in Humans at Risk for Cardiovascular Disease
Completed · Not applicable · Has a placebo group
Conditions studied: Obesity, Inflammation
In brief
The goal of the study is to determine whether grape consumption can reduce the risk of cardiovascular disease by reducing the presence of inflammatory molecules and positively altering cholesterol levels, lipid profiles, and immune cell responses.
Key facts
- Study ID
- NCT01443884
- Run by
- USDA, Western Human Nutrition Research Center
- People needed
- 24
- Starts
- 2009-10-01
- Expected to finish
- 2011-10-01
- Last updated by the study team
- 2011-12-12
Who can join
Age: 20 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- BMI 30 - 45 kg/m2
- Commitment to the dietary intervention and scheduled testing
You may not qualify if…
- Subjects will be excluded from this study if their blood cell counts or blood chemistry profiles are outside of the normal range
- smoking or use of tobacco products
- drink more than one alcoholic beverage per day (1 oz. distilled liquor, 3 oz. wine, or 12 oz. beer)
- taking cholesterol-lowering medications
- taking steroids for asthma or other inflammatory states
- taking thyroid-regulating drugs
- taking over-the counter weight loss products
Where it is running
- USDA, ARS, Western Human Nutrition Research Center — Davis, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.